| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |